UPDATE : Monday, September 7, 2020
상단여백
Court rejects Kolon’s appeal over Invossa license revocation
A Seoul court turned down Kolon Life Science’s appeal for stopping the gove...
by Jeong Sae-im  |  2019-09-25 11:18
라인
FDA recommends Kolon to remanufacture Invossa’s second fluid
The U.S. Food and Drug Administration has recommended Kolon TissueGene to r...
by Jeong Sae-im  |  2019-09-23 15:32
라인
Drug firms uncertain about pricing of quadrivalent flu vaccines
As the 2019-2020 flu season approaches, pharmaceutical firms are engaging i...
by Jeong Sae-im  |  2019-09-23 14:52
라인
‘Galderma Korea ran background checks on unionized workers’
The labor union of Galderma Korea, the local offshoot of a skin healthcare ...
by Jeong Sae-im  |  2019-09-19 15:18
라인
Regulator delays decision on delisting Kolon TissueGene
The Korea Exchange said it has delayed its decision whether to delist Kolon...
by Jeong Sae-im  |  2019-09-18 14:27
라인
Biotech startups seek IPO via ‘growth potential exception’ policy
An increasing number of biotech companies are eyeing on the Korea Exchange’...
by Jeong Sae-im  |  2019-09-17 11:26
라인
Chong Kun Dang wins patent suit against Novartis over immunosuppressant
Chong Kun Dang said it has won the lawsuit against Novartis over the patent...
by Jeong Sae-im  |  2019-09-11 15:16
라인
Daewoong to test botulinum toxin Nabota for hair loss
Daewoong Pharmaceutical said it would conduct a clinical trial on botulinum...
by Jeong Sae-im  |  2019-09-11 13:56
라인
Novartis withdraws suit against Ahngook’s generic drug
Novartis canceled its lawsuit against Ahngook Pharmaceutical’s anti-diabeti...
by Jeong Sae-im  |  2019-09-10 15:38
라인
Invossa victims furious at government, Kolon for ‘doing nothing’
“We’ve never heard when and how they would do a long-term follow-up. Kolon ...
by Jeong Sae-im  |  2019-09-09 15:47
라인
Nobel laureate Honjo anticipates best combo in immunotherapies
Professor Tasuku Honjo of Kyoto University said he was expecting a good out...
by Jeong Sae-im  |  2019-09-06 16:29
라인
Yuhan to expand biz scope to central nervous system disease
“We will broaden open innovation toward the academic sector and expand our ...
by Jeong Sae-im  |  2019-09-06 14:56
라인
SK goes global by developing new drugs, conducting CDMO biz
SK Holdings is integrating three pharmaceutical production subsidiaries aro...
by Jeong Sae-im  |  2019-09-03 14:58
라인
Hanmi, Daewoong among 20 innovative top-tier drugmakers in Asia Pacific
Hanmi Pharmaceutical and Daewoong Pharmaceutical were included in the top 2...
by Jeong Sae-im  |  2019-09-02 17:33
라인
JW Pharmaceutical’s hyperlipidemia drug Livalo safe from diabetes risk
JW Pharmaceutical said more countries have recognized that its cholesterol-...
by Jeong Sae-im  |  2019-08-30 14:49
라인
Change in licensing-out contract may be bad sign for Intron Biotechnology
Intron Biotechnology said the conditions for last November’s deal with a mu...
by Jeong Sae-im  |  2019-08-30 14:47
라인
Antidiabetic DPP-4 inhibitors mark double-digit sales growth
Inhibitors of dipeptidyl peptidase 4 (DPP-4), used to treat diabetes, have ...
by Jeong Sae-im  |  2019-08-29 11:24
라인
Sales of new gastric acid blocker K-Cab top ￦10 billion
CJ HealthCare’s K-Cab Tab., the nation’s 30th novel drug, recorded over 10 ...
by Jeong Sae-im  |  2019-08-28 13:26
라인
Invossa victims, Kolon shareholders demand apology, compensation
After the Korea Exchange’s Corporate Review Committee decided to delist Kol...
by Jeong Sae-im  |  2019-08-27 15:40
라인
HLB to test rivoceranib+Lonsurf in colon cancer
HLB said it would test a combination therapy using rivoceranib with Lonsurf...
by Jeong Sae-im  |  2019-08-27 15:39
-12345678910-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top